Vasoactive intestinal polypeptide (VIP) as a mediator of the watery diarrhea syndrome
- 1 September 1979
- journal article
- Published by Wiley in World Journal of Surgery
- Vol. 3 (5) , 559-563
- https://doi.org/10.1007/bf01654760
Abstract
Evidence that VIP is the principal humoral mediator of the watery diarrhea syndrome includes: (a) actions of VIP in experimental animals parallel the clinical manifestations of the syndrome; (b) infusions of VIP induce watery diarrhea in intestinal loops of dogs and a picture resembling the clinical syndrome in pigs, at circulating levels of the peptide similar to those observed in human disease; (c) most patients with the watery diarrhea syndrome and underlying tumors have elevated plasma levels of VIP; (d) in those patients in whom pre- and postoperative measurements were made, plasma VIP levels fell to the normal range with removal of the tumor and relief of the diarrhea; and (e) extracts of such tumors are rich in VIP-immunoreactivity and VIP-like biologic activity. A few patients with the syndrome have been reported to have normal plasma VIP levels, and it is possible that other humoral agents (such as pancreatic polypeptide, prostaglandins) may contribute to the production of the diarrhea. Que le VIP soit le principal médiateur humoral du syndrome de diarrhée aqueuse est démontré par: (a) l'effet du VIP chez l'animal: il reproduit les manifestations cliniques du syndrome; (b) la perfusion de VIP déclenche une diarrhée aqueuse chez le chien à anse intestinale isolée et un tableau comparable au syndrome clinique chez le porc, à des taux de peptides circulants similaires à ceux que l'on observe dans les cas cliniques; (c) la plupart des malades atteints du syndrome de diarrhée aqueuse avec tumeur ont des taux élevés de VIP; (d) lorsque les mesures ont été faites en pré — et postopératoire, l'ablation de la tumeur et la disparition de la diarrhée s'accompagnent d'un retour à la normale des taux plasmatiques de VIP; (e) les extraits tumoraux ont une immunoréactivité et une activité biologique importantes, comparables à celles du VIP. Quelques cas de syndrome de diarrhée aqueuse avec taux plasmatique de VIP normal ont été rapportés. Il est possible que d'autres agents humoraux (polypeptide pancréatique, prostaglandines par exemple) puissent jouer un rôle dans l'apparition de la diarrhée.Keywords
This publication has 39 references indexed in Scilit:
- Intestinal Secretion Induced by Vasoactive Intestinal PolypeptideJournal of Clinical Investigation, 1978
- Plasma vasoactive intestinal polypeptide (VIP) levels and intestinal ischaemiaCellular and Molecular Life Sciences, 1978
- Vasoactive intestinal peptide, the major mediator of the WDHA (pancreatic cholera) syndrome: Value of measurement in diagnosis and treatmentDigestive Diseases and Sciences, 1978
- Watery Diarrhea SyndromeAnnals of Surgery, 1978
- Indomethacin-Responsive Pancreatic CholeraNew England Journal of Medicine, 1977
- Intractable diarrheaDigestive Diseases and Sciences, 1977
- Suppression of Gastrin Release and Gastric Secretion by Gastric Inhibitory Polypeptide (GIP) and Vasoactive Intestinal Polypeptide (VIP)Annals of Surgery, 1976
- Vasoactive Intestinal Peptide Stimulation of Adenylate Cyclase and Active Electrolyte Secretion in Intestinal MucosaJournal of Clinical Investigation, 1974
- Isolation from Porcine‐Intestinal Wall of a Vasoactive Octacosapeptide Related to Secretin and to GlucagonEuropean Journal of Biochemistry, 1972
- Effects on Smooth Muscle Preparations of Unidentified Vasoactive Peptides from Intestine and LungNature, 1970